Therachon   Report issue

For profit Phase 2
Founded: Basel Switzerland (2014)
Status: Acquired by Pfizer (2019)

Organization Overview

First Clinical Trial
None
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
None

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Active Ingredients

Drugs in Phase 2 Trials (1)

Key: Therachon (0) Acquired (1)

fe203799 (3 trials)

Indications

Overview

  • Highest Phase: None
  • # of Trials: 3
  • # of Trial APIs: 1